 BRIDGEWATER, N.J., Oct. 06, 2022 GLOBE NEWSWIRE -- Hillstream BioPharma, Inc. Nasdaq: HILS Hillstream or the Company, a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging anti-cancer mechanism resulting in iron-mediated cell death for drug resistant and devastating cancers, today announced that Randy Milby, Founder and Chief Executive Officer will present in-person and host one-on-one meetings with investors at the following conferences: 